ARDX

ARDX

USD

Ardelyx Inc. Common Stock

$5.695-0.005 (-0.088%)

Preço em tempo real

Healthcare
Biotecnologia
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$5.700

Máximo

$5.780

Mínimo

$5.630

Volume

2.70M

Fundamentos da empresa

Capitalização de mercado

1.4B

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Volume médio

3.69M

Bolsa de valores

NGM

Moeda

USD

Faixa de 52 semanas

Mínimo $3.21Atual $5.695Máximo $6.78

Notícias relacionadas

Analyst Upgrades

Piper Sandler Maintains Neutral on Ardelyx, Raises Price Target to $10

Piper Sandler analyst Christopher Raymond maintains Ardelyx with a Neutral and raises the price target from $9 to $10.

Ver mais
Piper Sandler Maintains Neutral on Ardelyx, Raises Price Target to $10
GlobeNewswire

Ardelyx President and Chief Executive Officer Mike Raab to Participate in the Wedbush Rewind American Society of Nephrology 2025 Investor Conference

WALTHAM, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet

Ver mais
Ardelyx President and Chief Executive Officer Mike Raab to Participate in the Wedbush Rewind American Society of Nephrology 2025 Investor Conference
Analyst Upgrades

Citigroup Maintains Buy on Ardelyx, Raises Price Target to $11

Citigroup analyst Yigal Nochomovitz maintains Ardelyx with a Buy and raises the price target from $10 to $11.

Ver mais
Citigroup Maintains Buy on Ardelyx, Raises Price Target to $11
Analyst Upgrades

TD Cowen Maintains Buy on Ardelyx, Raises Price Target to $10

TD Cowen analyst Joseph Thome maintains Ardelyx with a Buy and raises the price target from $9 to $10.

Ver mais
TD Cowen Maintains Buy on Ardelyx, Raises Price Target to $10